Benzinga·2025-09-18 11:23Analyst Upgrades and Price Targets - Needham analyst Gil Blum upgraded Amicus Therapeutics, Inc. (FOLD) from Hold to Buy with a price target of $14, while shares closed at $7.97 [5] - RBC Capital analyst Walter Spracklin upgraded CSX Corporation (CSX) from Sector Perform to Outperform, raising the price target from $37 to $39, with shares closing at $32.77 [5] - Scotiabank analyst Alfonso Salazar upgraded Vale S.A. (VALE) from Sector Perform to Sector Outperform, setting a price target of $14, with shares closing at $10.88 [5] - RBC Capital analyst Piral Dadhania upgraded NIKE, Inc. (NKE) from Sector Perform to Outperform, increasing the price target from $76 to $90, while shares closed at $72.31 [5] - JP Morgan analyst Lisa Gill upgraded Aveanna Healthcare Holdings Inc. (AVAH) from Underweight to Neutral, raising the price target from $6 to $10, with shares closing at $8.08 [5]